search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Diagnostics Diagnostics


CRISPR-


hen Francisco Mojica, a research scientist at the University of Alicante, Spain, set out to study genetic repeats in bacterial organisms, he had no idea his research would set the pace for discoveries that would have a profound impact in the fields of diagnostics and genetic engineering. The big discovery came in the early ’90s when Mojica first noticed the repetitive sequences, which he later named “short regularly spaced repeats” or SRSRs, while studying Haloferax mediterranei, a type of archaea found in salt flats.


W 8


based detection


The discovery of CRISPR was a pivotal moment in the fi eld of genetic engineering, due to the ability to use it to enable site-specifi c editing of DNA. It’s been a decade since CRISPR was discovered and this particular application still hasn’t made it out of clinical trials and into the clinic. But that doesn’t mean the tool doesn’t have its uses, as we discovered when a plethora of CRISPR-based Covid-19 tests hit the market during the pandemic. Covid-19 is just a single use case for CRISPR in diagnostics, however, and Oladimeji Ewumi speaks to Bryan Dechario, CEO of Sherlock Biosciences, and Kevin Davies, executive editor of The CRISPR Journal, to learn how the genetic engineering tool is being used to develop improved testing protocols for diseases.


In 2001, after a decade of research that found similar sequences across a plethora of bacteria and archaea, Mojica and another researcher coined the term “CRISPR,” which stands for clustered regularly interspaced short palindromic repeats. The goal was to unify further research using a consistent terminology, as a research group led by another scientist, Ruud Jansen was using SPacers Interspersed Direct Repeats (SPIDR) to describe the same phenomenon. The naming convention was agreed, but neither group had a firm grasp on the significance of their findings.


Practical Patient Care / www.practical-patient-care.com


nobeastsofi erce/Shutterstock.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61